S.M. Ali Hussaini
Indian Institute of Chemical Technology
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by S.M. Ali Hussaini.
Bioorganic & Medicinal Chemistry Letters | 2015
Ahmed Kamal; Korrapati Suresh Babu; M.V.P.S. Vishnu Vardhan; S.M. Ali Hussaini; Rasala Mahesh; Siddiq Pasha Shaik; Abdullah Alarifi
A simple, mild and efficient method for the synthesis of pyrazolopyridine based spirooxindoles by the three-component reaction has been developed using sulfamic acid (H2NSO3H) as a green catalyst. The method involves use of water as a solvent which makes it eco-friendly. The catalyst used is readily available and is prominent for short reaction time, operational simplicity and high yields. After completion of the reaction the catalyst could be recovered and reused for up to four cycles without loss in catalytic activity. Employing this method a library of 34 compounds has been synthesized and investigated for their cytotoxicity against a panel of three human cancer cell lines. Some of the compounds like 4o and 4p exhibited remarkable cytotoxicities with IC50 values of 0.35μM and 1.92μM against MDA-MB-231 cell line.
RSC Advances | 2014
Ahmed Kamal; Korrapati Suresh Babu; Shaikh Faazil; S.M. Ali Hussaini; Anver Basha Shaik
A simple, greener and highly efficient method for the synthesis of functionalized quinoxalines has been developed employing L-proline as a catalyst in water. To the best of our knowledge this transformation is achieved for the first time using an organic catalyst. A small library of quinoxaline–sulphonamide conjugates have been synthesized using this protocol. The newly synthesized conjugates have been tested for their cytotoxicity and antimicrobial activity against several bacterial strains including one fungal strain. The majority of the compounds have exhibited significant cytotoxicity as well as antimicrobial activity. Compounds 5a, 5b and 5d were found to be promising with respect to both cytotoxicity and antimicrobial activity.
Bioorganic Chemistry | 2016
Ahmed Kamal; P.S. Srikanth; M.V.P.S. Vishnuvardhan; G. Bharath Kumar; Korrapati Suresh Babu; S.M. Ali Hussaini; Jeevak Sopanrao Kapure; Abdullah Alarifi
A new class of combretastatin linked 1,3,4-oxadiazoles were designed, synthesized and screened for their cytotoxic activity against five human cancer cell lines such as HeLa, DU-145, A549, MDA-MB-231 and B16. These compounds showed significant cytotoxicity with IC50 values in the range 0.118-54.32μM. Conjugate 5m displayed potent antiproliferative activity against DU-145 cell line. Flow cytometric analysis revealed that these compounds arrested the cell cycle in G2/M phase. Moreover, the tubulin polymerization assay and immunofluorescence analysis indicate that 5m exhibits potent inhibitory effect on the tubulin assembly. Further, DNA fragmentation and Hoecst staining assays confirm that 5m induces apoptosis. Molecular docking studies and competitive binding assay indicated that 5m effectively bind at the colchicine binding site of the tubulin.
European Journal of Medicinal Chemistry | 2018
A. Prasanth Saraswati; S.M. Ali Hussaini; Namballa Hari Krishna; Bathini Nagendra Babu; Ahmed Kamal
Glycogen Synthase Kinase-3 (GSK-3) is a serine/threonine kinase which is ubiquitously expressed and is regarded as a regulator for various cellular events and signalling pathways. It exists in two isoforms, GSK-3α and GSK-3β and can phosphorylate a wide range of substrates. Aberrancy in the GSK-3 activity can lead to various diseases like Alzheimers, diabetes, cancer, neurodegeneration etc., rendering it an attractive target to develop potent and specific inhibitors. The present review focuses on the recent developments in the area of GSK-3 inhibitors and also enlightens its therapeutic applicability in various disease conditions.
Bioorganic & Medicinal Chemistry Letters | 2016
Ahmed Kamal; Shaikh Faazil; S.M. Ali Hussaini; M. Janaki Ramaiah; Moku Balakrishna; Nibedita Patel; S.N.C.V.L. Pushpavalli; Manika Pal-Bhadra
A series of anilinonicotinyl linked pyrazolo[1,5-a]pyrimidine conjugates (6a-x) were synthesized and evaluated for their antiproliferative activity. Some of these conjugates exhibited promising cytotoxic effects in the MCF-7 cell line and among these 6a and 6c exhibited significant effects, apart from G2/M cell cycle arrest. Interestingly they showed profound effects on cyclin D1, Bcl-2 and survivin proteins that regulate breast cancer cell proliferation. Moreover, ER alpha protein expression was studied to understand regulatory role of these conjugates on estrogen activity in estrogen positive breast cancer cells like MCF-7 and compounds 6a and 6c reduced their activity.
Bioorganic & Medicinal Chemistry Letters | 2017
Thokhir B. Shaik; S.M. Ali Hussaini; V. Lakshma Nayak; M. Lakshmi Sucharitha; M. Shaheer Malik; Ahmed Kamal
Based on our previous results and literature precedence, a series of 2-anilinopyridinyl-benzothiazole Schiff bases were rationally designed by performing molecular modeling experiments on some selected molecules. The binding energies of the docked molecules were better than the E7010, and the Schiff base with trimethoxy group on benzothiazole moiety, 4y was the best. This was followed by the synthesis of a series of the designed molecules by a convenient synthetic route and evaluation of their anticancer potential. Most of the compounds have shown significant growth inhibition against the tested cell lines and the compound 4y exhibited good antiproliferative activity with a GI50 value of 3.8µM specifically against the cell line DU145. In agreement with the docking results, 4y exerted cytotoxicity by the disruption of the microtubule dynamics by inhibiting tubulin polymerization via effective binding into colchicine domain, comparable to E7010. Detailed binding modes of 4y with colchicine binding site of tubulin were studied by molecular docking. Furthermore, 4y induced apoptosis as evidenced by biological studies like mitochondrial membrane potential, caspase-3, and Annexin V-FITC assays.
Tetrahedron Letters | 2015
Ahmed Kamal; Korrapati Suresh Babu; S.M. Ali Hussaini; P.S. Srikanth; Moku Balakrishna; Abdullah Alarifi
Tetrahedron Letters | 2015
Ahmed Kamal; Korrapati Suresh Babu; S.M. Ali Hussaini; Rasala Mahesh; Abdullah Alarifi
Bioorganic & Medicinal Chemistry | 2014
Ahmed Kamal; S.M. Ali Hussaini; V. Lakshma Nayak; M. Shaheer Malik; M. Lakshmi Sucharitha; Md. Ashraf; Chandrakant Bagul
Organic and Biomolecular Chemistry | 2015
Ahmed Kamal; S.M. Ali Hussaini; M. Lakshmi Sucharitha; Y. Poornachandra; Faria Sultana; C. Ganesh Kumar